Hair loss treatments have a wide range of clinical therapies including low-level laser light therapy as well as 2 medications approved by the Food and Drug Administration (FDA): topical minoxidil and finasteride both of which I have pharmaceutically compounded into our Hair Growth Solution. Surgical options include follicular unit transplant (FUT) and follicular unit extraction (FUE) technique which I perform in the office with the state of the art Neo-Graft FUE Device.  These are outpatient procedures with excellent outcomes and minimal downtime. In addition to these existing medical and surgical options, minimally invasive, office-based procedure used to treat hair loss, typically secondary to androgenic alopecia (AGA). It consists of growth factors extracted from autologous blood obtained by venipuncture. This concentrated mix of growth factors is injected into areas of hair loss, stimulating hair regrowth.  This is a great stand alone procedure but is great add on to the FUE procedure to enhance new growth.

The technique was described in the field of hematology in the 1970s. Hematologists coined the term to describe a high-platelet product used for the treatment of thrombocytopenia. Within the fields of orthopedics and sports medicine, it has been shown to stimulate soft tissue and joint healing due to its high concentration of growth factors. Since the 1990s, it has been used to promote wound healing across a number of medical fields, including: 

Ophthalmology, Oral maxillofacial surgery, Cardiac surgery, Gynecology, Urology, and now we are seeing excellent results and extensive use in facial rejuvenation  and hair restoration!

Natalie Justicz, MD, Adeeb Derakhshan, MD, Jenny X. Chen, MD, Linda N. Lee, MD*

Facial Plast Surg Clin N Am 28 (2020) 181–18

Thanks for reading!  

For more information or to schedule an appointment please call the office at 480-419-6996 or feel free to email me directly at

Dr. Stefanie Maass PhD., FNP, FAARM